Key Considerations for the Successful Development of a Biologic: Seven Steps to Success

Understanding the biology of your therapeutic is key to effectively and efficiently progressing it from first principles, through safety assessment studies, and into clinical trials. The unique characteristics and specific biology of each large molecule therapeutic make it impossible to design a “one size fits all” approach to non-clinical development, requiring instead a design tailored to each molecule.  For efficient development strategies, this should include a thorough understanding of the disease and therapeutic biology as well as ensuring that the most appropriate studies are conducted to progress each molecule. Despite the need for unique approaches for each novel biologic, there are seven key steps that should be considered when developing biologics through non-clinical development in order to ensure effective and efficient progress.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Insights into Recent Developments in Protein A Chromatography

Advanstar Communications

Protein A-based chromatography is the primary method used to purify monoclonal antibodies (mAbs). Over the past decade, there has been significant development of Protein A media, resulting in both higher capacity and improved stability to meet the changing requirements of the industry. More improvements are to come. This 60-minute webcast will review:
Watch Now

Setting the Precedent for Artificial Intelligence and Full Laboratory Automation

COPAN Diagnostics is pleased to release presentations given at an event held during ASM Microbe 2023. During this popular live event guests learned about the benefits of using technology for improved laboratory results and faster turnaround times.
Watch Now

Facility Intensification and Cost Reduction using an Integrated Buffer Delivery Platform

on24

Outsourcing or implementing a streamlined buffer preparation and management systems allows biomanufacturers to considerably reduce floor usage, labor and costs. In this webinar, we will explore the benefits of an Integrated Buffer Delivery Platform.
Watch Now

Custom LNP formulation development - The new Early Formulation Screening Service as a key partner for success

Nucleic acids are known to be fragile payloads. To enable their safe and efficient delivery into cells, the RNA payload needs to be “packed” into a delivery vehicle, the lipid nanoparticles (LNP). This webinar gives insight into our capabilities for customized LNP formulation development for novel therapeutic modalities.
Watch Now

Spotlight

resources